REDI-CaP (Recovery of Erectile Dysfunction Induced in Prostate Cancer Patients). Innovative Management of Patients with Unfavorable Intermediate-Risk Prostate Cancer: a Special Focus on Quality of Life and Erectile Function Recovery
Latest Information Update: 23 Sep 2025
At a glance
- Drugs Relugolix (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Acronyms REDI-CaP
Most Recent Events
- 23 Sep 2025 New trial record